Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging

被引：58
|
作者：
Le, DA
Lipton, SA [1 ]
机构：
[1] Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA
[2] Massachusetts Gen Hosp, Stroke & Neurovasc Regulat Lab, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Stroke & Neurovasc Regulat Lab, Boston, MA USA
来源：
DRUGS & AGING | 2001年 / 18卷 / 10期
关键词：
D O I：
10.2165/00002512-200118100-00001
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
The N-methyl-D-aspartate (NMDA) receptor complex is a subtype of glutamate receptor and its dysfunction is involved in many neurological disorders associated with aging, including chronic pain, depression, stroke and Parkinson's disease. Multiple clinical trials using NMDA receptor antagonists have been aborted mainly due to the severe psychomimetic adverse effects of these drugs that occur before concentrations can reach an adequate level in the brain. In this review, we present the evidence that clinically safer NMDA antagonists such as memantine and nitroglycerin., and the combination drug nitro-memantine, are promising as drugs in treating neurodegenerative diseases.
引用
收藏
页码：717 / 724
页数：8
相关论文
共 50 条
  • [1] Potential and Current Use of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging
    Dean A. Le
    Stuart A. Lipton
    Drugs & Aging, 2001, 18 : 717 - 724
  • [2] N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics
    Brown, Dean G.
    Krupp, Johannes J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (08) : 749 - 770
  • [3] OXINDOLE N-METHYL-D-ASPARTATE (NMDA) ANTAGONISTS
    CHENARD, BL
    BUTLER, TW
    SHALABY, IA
    PROCHNIAK, MA
    KOE, BK
    FOX, CB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (01) : 91 - 94
  • [4] OXINDOLE N-METHYL-D-ASPARTATE (NMDA) ANTAGONISTS
    BUTLER, TW
    CHENARD, BL
    SHALABY, IA
    PROCHNIAK, MA
    KOE, BK
    FOX, CB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 69 - MEDI
  • [5] AUTORADIOGRAPHIC ASSESSMENT OF THE EFFECTS OF N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONISTS INVIVO
    MCCULLOCH, J
    IVERSEN, LL
    NEUROCHEMICAL RESEARCH, 1991, 16 (09) : 951 - 963
  • [6] Direct inhibition of N-methyl-D-aspartate (NMDA)-receptor function by antiglaucomatous β-antagonists
    Nagata, Tatsuo
    Ueno, Susumu
    Morita, Hirofumi
    Kubota, Toshiaki
    Toyohira, Yumiko
    Tsutsui, Masato
    Tawara, Akihiko
    Yanagihara, Nobuyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 (03) : 423 - 434
  • [7] Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists
    Ebert, B
    Thorkildsen, C
    Andersen, S
    Christrup, LL
    Hjeds, H
    BIOCHEMICAL PHARMACOLOGY, 1998, 56 (05) : 553 - 559
  • [8] NOVEL CPP ANALOGS AS POTENTIAL ANTAGONISTS OF THE N-METHYL-D-ASPARTATE RECEPTOR
    HAYS, SJ
    BIGGE, CF
    NOVAK, PM
    DRUMMOND, JT
    JOHNSON, G
    BOBOVSKI, TP
    BRAHCE, LJ
    COUGHENOUR, LL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 198 : 10 - MEDI
  • [9] N-methyl-D-aspartate receptor antagonists for migraine: A potential therapeutic approach
    Ye, Ruidong
    Kong, Xiangwei
    Han, Junliang
    Zhao, Gang
    MEDICAL HYPOTHESES, 2009, 72 (05) : 603 - 605
  • [10] N-METHYL-D-ASPARTATE (NMDA) ANTAGONISTS IN PARKINSONS-DISEASE
    KORNHUBER, J
    RIEDERER, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (04): : 427 - 427
12345